New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2013
08:04 EDTPHG, ICADiCAD, Invivo announce global strategic agreement for MRI solutions
Invivo, a Philips Healthcare Business (PHG), and iCAD, Inc. (ICAD) announced that the companies have entered into a global research, development, and commercial agreement. Under the agreement, iCAD will develop advanced MRI image analysis software products which Invivo will incorporate into its suite of MRI product solutions for global commercial sale. The first products are anticipated to be available in Q2 2013. The initial focus of the partnership will be the release of a next generation platform for prostate and breast imaging. Additional new product releases are also anticipated beginning the second half of 2013.
News For ICAD;PHG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
12:02 EDTICADiCAD management to meet with Craig Hallum
Subscribe for More Information
11:03 EDTPHGSamsung ranks first in 2014 EU patent applications
The European Patent Office reports that Samsung (SSNLF) was ranked first in number of European patent applications for 2014 with 2,541 applications filed. Philips (PHG) took second place with 2,317, Siemens (SIEGY) took third with 2,133, BASF (BASFY) took sixth with 1,530, Qualcomm (QCOM) took seventh with 1,459, Ericsson (ERIC) took ninth with 1,347, and Intel (INTC) took 10th with 1,054 applications filed.
February 24, 2015
16:57 EDTICADiCAD sees FY15 revenue $55M-$59M, one estimate $55.79M
The company expects adjusted EBITDA margin in the 16%-20% range.
16:56 EDTICADiCAD reports Q4 adjusted EPS 1c, one estimate 4c
Reports Q4 revenue $13.2M, one estimate $13.3M.
05:56 EDTPHGPhilips intends to separate Lighting business through IPO
Subscribe for More Information
February 13, 2015
08:06 EDTPHGPhilips downgraded to Underweight from Neutral at HSBC
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use